INJECTABLE DRUGS MARKET ANALYSIS

Market Concentration and Competitive Landscape

Close-monitor your Competitor's Move, Request sample copy

Increasing R&D investment by manufacturers

Pharmaceutical companies worldwide have substantially increased their spending on research and development activities over the past few years. Developing new and improved drug delivery mechanisms has been a key priority area. Injectable drug delivery offers several advantages over conventional oral administration such as targeted delivery, sustained release and quicker onset of action. These advantages  drive significant R&D efforts towards development of novel and specialized injectable drug formulations.

Modern biologics and large molecule drugs have exponential growth opportunities, however, pose delivery challenges. Injectables provide a viable solution through formulations like pre-filled syringes, auto-injectors and implantable pumps. Substantial investments are dedicated to applying advanced drug formulation and delivery technologies such as microencapsulation, nanoparticle drug carriers and controlled release injectable depots. Such innovations allow delivery of drugs which were previously considered unsuitable for injection. Complex biologics are increasingly being developed in safer, stable and patient friendly injectable forms.

Moreover, injectable drug digitization is revolutionizing medication management. Combination of drug delivery devices, sensors and connectivity platforms enable development of “Intelligent” injectables with capabilities like automatic dosing, wireless health monitoring. Such “Digital therapeutics” are being co-developed along with traditional injectable drugs to improve clinical outcomes. Significant R&D spending is focused on such combination product development approaches. Overall advancement in materials, engineering and data science boosts introduction of human centric specialized injectable products with augmented functionalities.